Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.1.1.37 (
DNA methyltransferase
)
4,983
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Neuronal Per Arnt Sim domain 4 (Npas4), a brain-specific helix-loop-helix transcription factor, was recently shown to regulate the development of GABAergic inhibitory neurons. Npas4 mRNA expression levels were decreased in the hippocampus of mice exposed to stress, which was accompanied by
brain dysfunction
. We have suggested that transient stress reduced Npas4 transcription through the glucocorticoid receptor. In the present report, we investigated the potential contribution of epigenetic modifications induced by stress on Npas4 gene expression. The Npas4 promoter region contains two CpG islands; in the hippocampus, chronic restraint stress increases the DNA methylation levels of both of these CpG islands. In the Neuro2a cell line, treatment with a
DNA methyltransferase
inhibitor, 5-aza-2'-deoxycytidine, increased Npas4 mRNA levels and markedly reduced the DNA methylation levels of CpG island 2 in the Npas4 promoter. The DNA methylation sites in CpG island 2 overlap with two cyclic adenosine monophosphate response element (CRE) sequences. Mutation of these CRE sequences reduced Npas4 promoter activity. These results suggest that transcription of the Npas4 gene is downregulated by stress through DNA methylation of its promoter.
...
PMID:Stress increases DNA methylation of the neuronal PAS domain 4 (Npas4) gene. 2622 56